Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-26-110340

Chief Financial Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

David Matthew T · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-14 Grant or award : show line 1 in the form +250,000 250,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-14 Grant or award : show line 2 in the form Stock Option (right to purchase) +250,000 250,000 D
Loading xslF345X06/ownership.xml…